Insider Paula Green plans 16,739-share Twist Bioscience (NASDAQ: TWST) sale

Rhea-AI Filing Summary

Twist Bioscience insider Paula Green filed a Form 144 to sell up to 16,739 shares of common stock through Fidelity Brokerage Services LLC on or around 02/17/2026 on NASDAQ, with an aggregate market value of 877,123.60.

The notice shows these shares against a baseline of 61,311,704 common shares outstanding. The securities to be sold were mainly acquired through restricted stock vesting and one employee stock purchase plan transaction between 09/19/2024 and 02/20/2025, generally as compensation.

The filing also lists prior sales by Paula Green over the past three months, totaling 2,942 common shares on several dates, for combined gross proceeds of 109,727.69. By signing, the seller represents having no undisclosed material adverse information about Twist Bioscience’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16739	877123.60	61311704	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/19/2024	Restricted Stock Vesting	Issuer			311	09/19/2024	Compensation
Common	10/01/2024	Restricted Stock Vesting	Issuer			3615	10/01/2024	Compensation
Common	11/02/2024	Restricted Stock Vesting	Issuer			1162	11/02/2024	Compensation
Common	11/05/2024	Restricted Stock Vesting	Issuer			6481	11/05/2024	Compensation
Common	11/08/2024	Restricted Stock Vesting	Issuer			1647	11/08/2024	Compensation
Common	12/05/2024	Restricted Stock Vesting	Issuer			1015	12/05/2024	Compensation
Common	12/19/2024	Restricted Stock Vesting	Issuer			326	12/19/2024	Compensation
Common	01/01/2025	Restricted Stock Vesting	Issuer			130	01/01/2025	Compensation
Common	02/02/2025	Restricted Stock Vesting	Issuer			960	02/02/2025	Compensation
Common	02/20/2025	ESPP Purchase	Issuer			434	02/20/2025	Cash
Common	02/20/2025	Restricted Stock Vesting	Issuer			658	02/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	11/21/2025	598	15849.09
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	12/08/2025	877	28833.66
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	12/22/2025	273	9433.79
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	02/03/2026	1194	55611.15

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Twist Bioscience (TWST) insider Paula Green’s Form 144 filing show?

The Form 144 shows Paula Green intends to sell up to 16,739 Twist Bioscience common shares on NASDAQ, valued at about 877,123.60. It discloses how the shares were acquired, recent prior sales, and affirms no undisclosed material adverse information about the company.

How many Twist Bioscience (TWST) shares are covered by this Form 144 notice?

The notice covers up to 16,739 Twist Bioscience common shares proposed for sale. These shares correspond to an aggregate market value of about 877,123.60. The filing specifies that trading would occur through Fidelity Brokerage Services LLC on or around 02/17/2026 on NASDAQ.

How were the Twist Bioscience (TWST) shares in Paula Green’s Form 144 acquired?

The shares were primarily acquired through restricted stock vesting transactions and one employee stock purchase plan buy from the issuer between 09/19/2024 and 02/20/2025. Most are labeled as compensation, with one cash ESPP purchase of 434 common shares on 02/20/2025.

What recent Twist Bioscience (TWST) stock sales by Paula Green are disclosed?

The filing lists four sales over the past three months: 598 shares on 11/21/2025, 877 on 12/08/2025, 273 on 12/22/2025, and 1,194 on 02/03/2026. Combined, these sales totaled 2,942 shares for gross proceeds of 109,727.69.

How many Twist Bioscience (TWST) shares are outstanding relative to Paula Green’s planned sale?

The document states 61,311,704 Twist Bioscience common shares outstanding. Paula Green’s Form 144 covers a proposed sale of 16,739 shares. The outstanding share count provides a baseline to understand the relative size of this prospective sale within the company’s total equity.

What representations does Paula Green make in the Twist Bioscience (TWST) Form 144?

By signing the notice, Paula Green represents that she does not know any material adverse information about Twist Bioscience’s current or prospective operations that has not been publicly disclosed. The form also warns that intentional misstatements or omissions can be federal criminal violations under 18 U.S.C. 1001.